prostate disorders - Nursing Case Study

Pathophysiology

• Primary mechanism: Hormonal imbalance, particularly increased levels of dihydrotestosterone (DHT), leads to prostate tissue growth and can result in benign prostatic hyperplasia (BPH), causing urinary obstruction due to prostate enlargement.

• Secondary mechanism: Chronic inflammation, potentially due to infections or autoimmune responses, can contribute to cellular changes and proliferation within the prostate, increasing the risk for conditions like prostatitis or prostate cancer.

• Key complication: Urinary retention and incomplete bladder emptying are common in BPH, which can cause recurrent urinary tract infections and potentially lead to kidney damage if not managed appropriately.

Patient Profile

Demographics:

67-year-old male, retired factory worker

History:

• Key past medical history: Benign prostatic hyperplasia diagnosed 5 years ago, hypertension, hyperlipidemia

• Current medications: Tamsulosin, Lisinopril, Atorvastatin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Difficulty urinating with increased frequency

• Key symptoms: Nocturia, weak urine stream, pelvic discomfort, occasional blood in urine, fatigue

• Vital signs: Blood pressure 145/90 mmHg, heart rate 88 bpm, respiratory rate 18 breaths per minute, temperature 98.6°F

Section 1

During the initial assessment, the healthcare team noted several concerning findings. The patient exhibited notable suprapubic tenderness upon palpation, which could indicate bladder distension due to urinary retention. A bladder scan revealed a post-void residual volume of 250 mL, suggesting significant urinary retention. Given the patient's history of benign prostatic hyperplasia and his current symptoms, this finding aligns with an exacerbation of his BPH. Laboratory tests were ordered, including a complete blood count (CBC) and a basic metabolic panel (BMP), to assess for signs of infection or renal impairment. The CBC showed a slightly elevated white blood cell count at 11,000/mm³, which could suggest an inflammatory or infectious process, while the BMP showed a creatinine level of 1.4 mg/dL, slightly above normal, indicating possible early renal involvement.

A digital rectal exam (DRE) was performed, revealing an enlarged prostate with a smooth, firm texture, consistent with BPH but not excluding other potential issues such as prostatitis or prostate cancer. This prompted the healthcare provider to order a prostate-specific antigen (PSA) test to further evaluate the risk of malignancy. The patient's PSA level returned at 5.5 ng/mL, which is elevated given his age, and warrants further investigation with a possible referral to a urologist for a transrectal ultrasound and biopsy as needed.

In response to these findings, the primary intervention was the insertion of a Foley catheter to relieve the urinary retention, which resulted in the immediate drainage of 600 mL of urine, providing significant relief of symptoms. The plan now includes monitoring renal function closely, addressing the potential for infection with a urine culture, and evaluating the need for antibiotic treatment. The patient's medication regimen will also be reviewed to optimize management of his BPH and prevent further complications, emphasizing the importance of patient education on recognizing symptoms of urinary obstruction and infection.

Section 2

After the Foley catheter insertion and initial relief of symptoms, the patient's condition was closely monitored. Over the next 24 hours, the patient began to exhibit signs of a potential urinary tract infection (UTI), including a low-grade fever of 100.4°F (38°C), increased suprapubic discomfort, and new onset of dysuria despite catheterization. The urine culture, which was previously ordered, returned positive for Escherichia coli, indicating a bacterial infection likely secondary to urinary stasis and catheter use. Given the patient's slightly elevated creatinine level and history of BPH, there is concern regarding the impact of the infection on his renal function.

The healthcare team initiated a course of antibiotics, selecting an agent based on the sensitivity profile of the cultured organism. The patient's vital signs were carefully monitored, with particular attention to his blood pressure, which was noted to be slightly elevated at 145/90 mmHg, potentially reflecting discomfort or an underlying stress response to the infection. To mitigate potential complications, the team emphasized the importance of maintaining adequate hydration, monitoring urine output, and reassessing renal function through follow-up BMP and creatinine levels.

The development of a UTI presents a moderate complication in the management of this patient and highlights the delicate balance required in treating BPH with concurrent urinary retention. The clinical team must now focus on addressing the infection promptly to prevent further renal impairment, while also considering adjustments to the patient's BPH management plan to minimize future episodes of urinary retention and infection. This includes reevaluating his current medications, such as alpha-blockers or 5-alpha reductase inhibitors, and potentially exploring minimally invasive surgical options if conservative management proves inadequate. The patient's progress and response to treatment will be reassessed in 48 hours, with a particular focus on symptomatic improvement, renal function stabilization, and normalization of vital signs.

Section 3

Two days following the initiation of antibiotic therapy, the patient experienced a notable change in status. While his fever resolved, the patient began to report increased fatigue and a persistent dull ache in his lower back, raising concerns about potential pyelonephritis. Vital signs showed a slight improvement with temperature returning to normal limits, but his blood pressure remained elevated at 148/92 mmHg. Urine output decreased to less than 30 mL/hr, raising alarms about possible acute kidney injury. In light of these developments, a repeat basic metabolic panel (BMP) was ordered, revealing a further increase in creatinine levels to 2.1 mg/dL, indicating worsening renal function.

The clinical team convened to discuss these findings, recognizing the need to intensify their management approach. A renal ultrasound was ordered to assess for any obstruction or changes in the kidneys that might explain the deterioration in renal function. Furthermore, the patient's medication regimen was reviewed, and adjustments were made to optimize his blood pressure control and enhance renal perfusion. To address the potential progression of infection, the antibiotic therapy was reassessed, considering the addition of a broader spectrum agent while awaiting further imaging results. The importance of maintaining strict input-output monitoring and ensuring adequate hydration was reinforced to all involved in the patient's care.

As the team awaits further diagnostic results, they continue to focus on stabilizing the patient's renal function and preventing progression to more severe complications. This situation demands careful clinical reasoning to weigh the benefits and risks of potential interventions, such as adjusting medications or considering procedural options for his BPH, to ensure a comprehensive approach to his evolving clinical picture. The patient's response to these interventions will be closely monitored, with the aim of achieving symptomatic relief and renal function stabilization to guide the next steps in his management plan.

Section 4

As the team awaited the renal ultrasound results, the patient's clinical status exhibited further changes that necessitated immediate attention. Despite the adjustments in his medication regimen, the patient began to experience increased shortness of breath and a sensation of palpitations. Vital signs now revealed tachycardia with a heart rate of 112 beats per minute and a blood pressure of 154/98 mmHg, indicating continued hypertension. His respiratory rate increased to 24 breaths per minute, and oxygen saturation dropped to 92% on room air, suggesting potential fluid overload or worsening cardiac function.

The repeat basic metabolic panel showed a concerning rise in potassium levels to 5.6 mEq/L, alongside a further increase in creatinine to 2.3 mg/dL. These laboratory findings raised the suspicion of hyperkalemia and potential cardiac complications. With these developments, the clinical team prioritized immediate interventions to address the electrolyte imbalance and prevent any cardiac arrhythmias. Diuretics were considered to manage fluid overload, but the risk of further compromising renal function required careful deliberation.

Simultaneously, the renal ultrasound results returned, revealing mild hydronephrosis in the right kidney, suggestive of possible obstruction due to benign prostatic hyperplasia (BPH). This finding prompted the team to reevaluate procedural options, such as catheterization or surgical intervention, to relieve the obstruction and improve renal perfusion. The patient's deteriorating condition necessitated a multidisciplinary approach, weighing the risks and benefits of each potential intervention to stabilize his renal function, address cardiovascular concerns, and plan the next steps in his comprehensive management strategy.

Section 5

The clinical team decided to focus on immediate intervention for the hyperkalemia, given the potential risks of cardiac arrhythmias. Calcium gluconate was administered to stabilize the cardiac membrane, while a combination of insulin and glucose was given to facilitate the intracellular shift of potassium. Concurrently, preparations were made for the administration of a potassium-binding resin to promote the elimination of excess potassium through the gastrointestinal tract. These measures quickly brought the potassium levels down to 5.0 mEq/L, offering a temporary reprieve from the risk of life-threatening arrhythmias.

As these interventions were underway, the patient's respiratory status showed signs of further decline. Despite the correction of hyperkalemia, his oxygen saturation remained low at 90% on room air, and he began to exhibit peripheral edema, particularly in the lower extremities. This prompted the team to suspect an exacerbation of heart failure secondary to fluid overload, likely compounded by the renal impairment. A decision was made to cautiously initiate low-dose furosemide, closely monitoring for any adverse effects on renal function. In addition, supplemental oxygen therapy was started to improve hypoxemia, and a cardiology consult was requested for further evaluation.

While addressing these acute concerns, the team also revisited the renal ultrasound findings of mild hydronephrosis due to BPH. Given the ongoing renal compromise and fluid retention, a urology consult was sought to discuss potential procedural interventions such as catheterization or transurethral resection of the prostate (TURP). The aim was to relieve the obstruction and mitigate the risk of further renal deterioration. With a multidisciplinary team in place, the focus was now on stabilizing the patient while planning a comprehensive approach to manage his complex clinical picture.